Online Medical Classes

Medical Transcription Companies News

MedQuist Pays Kaiser $2M to Settle Suit - cblWednesday, August 18, 2010 @ 10:22PMBy citybizlist StaffMOUNT LAUREL, N.J. -- MedQuist Inc. (NASDAQ: MEDQ), a medical transcription comp...

Medical Transcription Industry Association to change name to Clinical Documentation Industry AssociationWednesday, August 18, 2010 @ 7:50AMProviding innovative solutions for EHR adoption that facilitate accurate and timely capture of health information continues to be a key message for the Medical Transcription Industry Association, whose members recently voted to change its name to Clinical Documentation Industry Association (CDIA) in an effort to reflect not only the expanded scope of services its members provide to the ...

Medical Transcription Industry Association Changes Name After 20 Years to Reflect Expanded Services in the Healthcare ...Wednesday, August 18, 2010 @ 6:09AMMODESTO, Calif.--(BUSINESS WIRE)--Providing innovative solutions for EHR adoption that facilitate accurate and timely capture of health information continues to be a key message for the Medical Transcription Industry Association, whose members recently voted to change its name to Clinical Documentation Industry Association (CDIA) in an effort to reflect not only the expanded scope of services ...

Oakton Community College briefsThursday, August 5, 2010 @ 4:08AMStudents interested in pursuing a career in health care are invited to attend free information sessions in August at Oakton Community College, 1600 E. Golf Road, Des Plaines.

Press ReleaseMonday, August 2, 2010 @ 10:34AMRegeneRx Biopharmaceuticals Inc. Posted on:02 Aug 10 RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) (“the Company� or “RegeneRx�) today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4 (Tß4), is essential to healthy heart development and embryonic survival.

British Researchers Report that TB4 is Essential to Heart DevelopmentMonday, August 2, 2010 @ 7:43AMROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) (“the Company” or “RegeneRx”) today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4 (Tβ4), is essential to healthy heart development and embryonic survival. The research was conducted by Drs. Nicola Smart ...

British Researchers Report that TB4 is Essential to Heart DevelopmentMonday, August 2, 2010 @ 7:30AMROCKVILLE, Md.----RegeneRx Biopharmaceuticals, Inc. today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4 , is essential to healthy heart development and embryonic survival.

Regulate? Don't Regulate? Let's Do Both!Thursday, July 29, 2010 @ 9:55AMWill regulation of the direct-to-consumer genetic testing industry kill the personal genomics initiative, or will it protect consumers from companies with products of questionable value? To regulate or not to regulate has been the question on everyone's minds.

New Technology Solution Relieves Doctors of Time-Consuming Data Entry When Using EMRs, According to Emdat White PaperWednesday, July 28, 2010 @ 5:35PMFITCHBURG, Wis.----A new method of populating electronic medical records that pulls patient information directly from a medical transcription enables physicians to keep their daily workflow the same, according to a white paper released today by Emdat, a provider of web-based medical transcription software.